Common Contracts
3 similar Executive Change in Control Agreement contracts by GTC Biotherapeutics Inc
EXECUTIVE CHANGE IN CONTROL AGREEMENTExecutive Change in Control Agreement • November 10th, 2004 • GTC Biotherapeutics Inc • Biological products, (no disgnostic substances) • Massachusetts
This Executive Change in Control Agreement (this “Agreement”) is dated as of August 16, 2004 by and between GTC Biotherapeutics, Inc. (the “Company”), a Massachusetts corporation with its principal executive offices at 175 Crossing Boulevard, 4th Floor, Suite 410, Framingham, MA 01702-9322; and Gregory F. Liposky (“Executive”).
EXECUTIVE CHANGE IN CONTROL AGREEMENTExecutive Change in Control Agreement • November 10th, 2004 • GTC Biotherapeutics Inc • Biological products, (no disgnostic substances) • Massachusetts
This Executive Change in Control Agreement (this “Agreement”) is dated as of August 16, 2004 by and between GTC Biotherapeutics, Inc. (the “Company”), a Massachusetts corporation with its principal executive offices at 175 Crossing Boulevard, 4th Floor, Suite 410, Framingham, MA 01702-9322; and Daniel S. Woloshen (“Executive”).
EXECUTIVE CHANGE IN CONTROL AGREEMENTExecutive Change in Control Agreement • November 10th, 2004 • GTC Biotherapeutics Inc • Biological products, (no disgnostic substances) • Massachusetts
This Executive Change in Control Agreement (this “Agreement”) is dated as of August 16, 2004 by and between GTC Biotherapeutics, Inc. (the “Company”), a Massachusetts corporation with its principal executive offices at 175 Crossing Boulevard, 4th Floor, Suite 410, Framingham, MA 01702-9322; and Harry M. Meade, Ph.D. (“Executive”).
